Bmi Doctors

Switching from another GLP-1 to Semaglutide

Table of Contents

Transitioning to BMI Doctors' Semaglutide Program

This article is intended for individuals that are:

          Currently a weight loss patient with another practice and considering switching to BMI Doctors semaglutide program.

          Currently taking GLP-1 medications such as Ozempic®, Wegovy®, Rybelsus®, Mounjaro®, or other and looking to switch to BMI Doctors semaglutide program. 

o   Note that The Semaglutide you may be prescribed is a compounded medication and is not associated with the Novo Nordisk™ company or the brand-name medications Wegovy®, Ozempic®, or Rybelsus®. Mounjaro® is a registered trademark of Eli Lilly and Company. Wegovy®, Ozempic®, and Rybelsus® are registered trademarks of the Novo Nordisk™ company. BMI Doctors is an independent entity and is not affiliated with, sponsored by, or endorsed by Novo Nordisk, Eli Lilly or any other pharmaceutical company.

An important step of this transition is the comprehensive hormone panel blood test taken at Quest Diagnostics. This blood test panel allows for a deeper understanding of each patient’s unique hormonal profile, paving the way for a more effective and customized treatment plan.

As part of the transition, it is imperative for patients to meticulously disclose their current medication details, including specific dosages and injection protocols, in the medical history section of BMI Doctors’ patient onboarding forms. This information is vital in crafting a seamless and safe transition to the semaglutide program, ensuring that each patient’s journey towards better health is as smooth and effective as possible.

Transition Considerations

However, transitioning between different GLP-1 medications, such as moving from Ozempic® to the semaglutide program at BMI Doctors, requires careful consideration. Each medication has its unique profile, and understanding the nuances of these treatments is crucial for a safe and effective transition. It’s vital for patients to work closely with healthcare providers to understand the benefits, potential side effects, and the best course of action tailored to their individual health needs.

Why Switch to Semaglutide at BMI Doctors?

Choosing the right weight loss medication is a critical decision, and when it comes to both effectiveness and affordability, BMI Doctors’ semaglutide program stands out. Priced at $249 per month, this program is not just a medication plan but a comprehensive weight loss solution.

Cost-Effective Comprehensive Care

At BMI Doctors, the transparent pricing model is a significant draw. For $249 per month, patients receive semaglutide medication, in-depth doctor consultations, and comprehensive blood work at Quest Diagnostics. This all-inclusive pricing contrasts sharply with other clinics where such services often incur additional costs. Additionally, the cost includes 2nd-day air shipping of medications with no hidden fees, providing patients with a hassle-free experience.

Quarterly Billing for Budget Management

To further enhance affordability, BMI Doctors bills patients quarterly, equating to $747 every three months. This billing method not only simplifies budgeting but also minimizes shipping expenses by providing a three-month supply of medication in each shipment so that patients are not impacted when medication shortages are experienced.

Unmatched Benefits Beyond Medication

Beyond the medication, the program offers extensive benefits like unlimited access to U.S. board-certified doctors, a patient care team, and around-the-clock family telemedicine services. This holistic approach to patient care is rare and valuable, especially in the field of weight management.

Eliminating Insurance Complexities

A notable advantage of BMI Doctors’ program is its independence from insurance requirements. This factor removes a significant barrier many face with weight loss treatments, making the program accessible to a wider audience.

The combination of transparent, all-inclusive pricing, comprehensive care, and additional benefits makes the semaglutide program at BMI Doctors an attractive and practical choice. This program is designed not only to be cost-effective but also to ensure that patients receive a full spectrum of support throughout their weight management journey, making it an appealing option for those considering a switch from other GLP-1 medications.

Transitioning to BMI Doctors' Semaglutide Program

Embarking on a journey with BMI Doctors’ semaglutide program signifies a commitment to a more personalized and effective approach to weight management. The transition process, designed with patient care and convenience in mind, is a structured pathway ensuring a smooth and efficient switch.

Step 1: On-Boarding forms, Medical History and Medication Review

Patients are required to complete our on-boarding forms and to provide detailed medical history, including their current and past usage of GLP-1 medications. Disclosing specific dosages and injection protocols is essential. This information is critical in determining the most effective semaglutide dosing and to ensure a safe transition from their current medication.

Step 2: Comprehensive Hormone Panel at Quest Diagnostics

A unique aspect of the BMI Doctors program is the comprehensive hormone panel conducted at Quest Diagnostics. This detailed analysis provides invaluable insights into the patient’s hormonal balance, which plays a pivotal role in weight management. Understanding hormonal influences helps in tailoring the semaglutide treatment to everyone’s unique physiology. This lab work is included in the price and you can visit any Quest Diagnostics facility closest to you.

Step 3: Patient Consultation and Assessment

Our patient support team will schedule your in-depth initial consultation with one of our board-certified Doctors. Here, patients meet with expert physicians to discuss their medical history, previous experiences with weight loss medications, and specific needs. This step is crucial for establishing a foundation for personalized treatment.

Step 4: Developing a Customized Treatment Plan

Based on the consultation, hormone panel results, and medical history, BMI Doctors’ team crafts a customized treatment plan. This plan integrates the semaglutide medication with lifestyle recommendations, dietary advice, and any necessary adjustments based on the patient’s health status and goals. It’s at this point that our Doctors will recommend the details on transitioning from your current GLP-1 medication to our semaglutide program.

Step 5: Ongoing Support and Monitoring

Once the treatment plan is in place, patients receive ongoing support and monitoring. Regular follow-ups are scheduled to track progress, make any necessary adjustments to the treatment, and provide continuous support and guidance. This ongoing care is vital for long-term success and patient satisfaction.

Step 6: Seamless Medication Delivery

Medications are shipped directly to the patient, ensuring a seamless and convenient process. The quarterly shipment of a three-month supply reduces the hassle of frequent refills and aligns with the billing cycle for easier budget management.

Transitioning to BMI Doctors’ semaglutide program is more than a medication switch; it’s a step towards a more tailored, comprehensive, and supportive approach to weight management. Every stage of the process, from the initial assessment to ongoing care, is designed with the patient’s well-being and convenience in mind, making it a commendable choice for those seeking a change in their weight loss journey.

Preparing for the Switch to BMI Doctors' Semaglutide Program

Transitioning to a new weight loss program is a significant step. For those moving to BMI Doctors’ semaglutide program, thorough preparation is key to ensuring a smooth and effective change. This preparation involves several critical steps, each designed to tailor the treatment to the individual’s unique health profile.

Completing Detailed Medical History Forms

One of the first steps in the transition is the completion of detailed medical history forms. These forms are crucial as they provide BMI Doctors with essential information about the patient’s past and current medical conditions, treatments, and specifically, their experiences with GLP-1 medications. Accurate and comprehensive information enables the medical team to understand the patient’s health journey and to anticipate their needs in the new program.

Disclosure of Dosage and Injection Protocol

For patients previously on GLP-1 medications like Ozempic®, Wegovy®, Rybelsus®, or Mounjaro®, it’s vital to disclose the specific dosages and injection protocols. This information is instrumental in determining the appropriate starting dose of semaglutide and in making any necessary adjustments to optimize treatment efficacy while minimizing potential side effects.

Understanding the Role of the Comprehensive Hormone Panel

Another critical aspect of preparation is the comprehensive hormone panel conducted at Quest Diagnostics. Patients should understand the importance of this step, as the results provide insights into various hormonal factors that could affect weight loss and overall health. This panel aids in creating a more personalized treatment plan.

Setting Realistic Expectations and Goals

Transitioning to the semaglutide program also involves setting realistic expectations and goals. During the initial consultation, BMI Doctors’ healthcare professionals work with patients to establish achievable targets based on their health status and weight loss objectives. This collaborative approach ensures that patients are mentally and emotionally prepared for their journey.

Preparing for the switch to BMI Doctors’ semaglutide program requires attention to detail and open communication between the patient and healthcare provider. By thoroughly completing medical forms, openly discussing past treatments, and understanding the comprehensive nature of the program, patients can embark on their new weight loss journey with confidence, supported by a team dedicated to their success.

The BMI Doctors Approach to Weight Management

The BMI Doctors’ approach to weight management transcends traditional methods by offering a program that is as innovative as it is patient centric. This approach is built on the foundation of personalized care, ensuring that each patient’s journey towards weight loss is tailored to their unique needs and circumstances.

Personalized Care and Treatment

At BMI Doctors, the belief is that every patient’s weight loss journey is unique. This philosophy is reflected in the personalized care provided to each individual. The medical team takes the time to understand not just the patient’s medical history and current health status, but also their lifestyle, dietary habits, and personal challenges. This comprehensive understanding allows the team to create a treatment plan that aligns with the patient’s specific needs and goals.

Integration of Semaglutide into Holistic Treatment Plans

Semaglutide, a key component of the program, is integrated into a broader, holistic treatment plan. This plan may include nutritional counseling, lifestyle adjustments, and behavioral therapy, ensuring that patients receive a multifaceted approach to weight management. Semaglutide is not just seen as a medication, but as a tool that works in concert with other elements of the program to achieve optimal results.

Regular Monitoring and Adjustments

BMI Doctors places a strong emphasis on regular monitoring and follow-up. This ongoing care allows for the adjustment of treatment plans as needed, ensuring that each patient continues to make progress towards their goals. Regular check-ins also provide an opportunity for patients to discuss any challenges they’re facing, allowing for timely interventions and support.

Support Beyond Medication

The support offered by BMI Doctors extends beyond medication management. Patients have access to a team of professionals, including nutritionists, fitness experts, and mental health counselors, all of whom play a vital role in supporting the patient’s overall well-being. This multidisciplinary team works together to address all aspects of weight loss, from physical health to emotional and psychological well-being.

Educational Resources and Community Support

BMI Doctors also provides patients with a wealth of educational resources and access to a supportive community. Educational materials help patients understand their treatment and how lifestyle factors affect weight loss. Community support, whether through group sessions or online forums, offers a platform for patients to share experiences, seek advice, and find encouragement from others on similar journeys.

The BMI Doctors approach to weight management is a testament to their commitment to providing comprehensive, personalized, and supportive care. By focusing on the individual needs of each patient and integrating semaglutide into a holistic treatment plan, BMI Doctors ensures that patients are not only successful in their weight loss journey but are also empowered to maintain their results in the long term. As a next step, be sure to review the semaglutide pricing page and then proceed to complete the patient on-boarding forms.

Research Citations

Here are some research citations related to switching from other GLP-1 receptor agonists to semaglutide:

  1. Pratley RE, Aroda VR, Lingvay I, et al. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. Lancet Diabetes Endocrinol. 2018;6(4):275-286. doi:10.1016/S2213-8587(18)30024-X
  2. Marso SP, Bain SC, Consoli A, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375(19):1834-1844. doi:10.1056/NEJMoa1607141
  3. Rosenstock J, Diamant M, Aroda VR, et al. Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7(11):834-844. doi:10.1016/S2213-8587(19)30249-9
  4. Mosenzon O, Blicher TM, Rosenlund S, et al. Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3A trial. Lancet Diabetes Endocrinol. 2019;7(7):515-527. doi:10.1016/S2213-8587(19)30192-X
  5. Blonde L, Russell-Jones D. The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies. Diabetes Obes Metab. 2009;11(Suppl 3):26-34. doi:10.1111/j.1463-1326.2009.01084.x
  6. Bain SC, Marso SP, Neal B, et al. Efficacy and safety of semaglutide compared with dulaglutide, exenatide, and liraglutide in type 2 diabetes: The SUSTAIN 7 network meta-analysis. Diabetes Obes Metab. 2021;23(4):1111-1120. doi:10.1111/dom.14331
  7. Frias JP, Nauck MA, Van J, Kutner ME, Cui X, Benson C. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Lancet. 2018;392(10160):2180-2193. doi:10.1016/S0140-6736(18)32260-8
  8. Davies MJ, Bergenstal R, Bode B, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE Diabetes Randomized Clinical Trial. JAMA. 2015;314(7):687-699. doi:10.1001/jama.2015.9676

These studies provide insights into the efficacy and safety of switching from other GLP-1 receptor agonists to semaglutide in the management of type 2 diabetes. However, it’s essential to consult with a healthcare provider before making any changes to medication regimens.

Questions and Answers: Switching from other GLP-1 medications to Semaglutide

Patients might switch due to side effects like gastrointestinal discomfort, a desire for better glycemic or weight control, issues with the injection device, seeking a weekly instead of daily medication, or changes in insurance coverage.

The process usually involves consulting with your healthcare provider to evaluate your current regimen, discussing your medical history, and considering the specific attributes of the new medication. A gradual transition with dosage adjustments might be necessary.

In some cases, like switching from dulaglutide to semaglutide, it’s possible to directly switch to a therapeutically equivalent dose (e.g., from 1.5 mg of dulaglutide to 0.5 mg of semaglutide weekly) to avoid a period of subtherapeutic dosage.

Each GLP-1 medication has its own risk profile. For instance, semaglutide may carry a risk for retinopathy due to its glucose-lowering effect. It’s important to discuss these risks with your healthcare provider and ensure regular health check-ups, like eye exams.

If you experience side effects, especially gastrointestinal ones, after a dose increase, consult with your healthcare provider. They may advise eating smaller portions, avoiding fatty foods, or adjusting the medication dose.

If you start with a lower dose of the new medication, like 0.25 mg of semaglutide, you may experience higher blood sugar levels temporarily. This should improve once the dose is adjusted to a therapeutic level.

Adjustment periods can vary. For instance, when starting semaglutide, it may take several weeks to reach a therapeutically effective dose. During this period, monitoring blood sugar levels and general health is crucial.

If you have significant issues with the new medication, your healthcare provider may consider adjusting the dose, switching back, or trying a different GLP-1 medication.

Yes, cost is a common reason for switching, especially if a particular GLP-1 medication becomes more affordable due to changes in drug pricing or insurance coverage.

Your diet and exercise routines may not need to change significantly, but it’s always beneficial to maintain a healthy lifestyle. Discuss any specific recommendations with your healthcare provider, especially if the new medication has different effects on appetite or metabolism.

Dr. Melissa VanSickle

Dr. Melissa VanSickle

Dr. Melissa Vansickle, MD is a family medicine specialist in Onsted, MI and has over 24 years of experience in the medical field. She graduated from University of Michigan Medical School in 1998. She is affiliated with medical facilities Henry Ford Allegiance Health and Promedica Charles And Virginia Hickman Hospital. Her subspecialties include General Family Medicine, Urgent Care, Complementary and Integrative Medicine in Rural Health.

Skip to content